NIH-funded research R01 grant

Using platelet-mitochondria to treat kidney injury

Official title: Platelet-mitochondria transplantation to treat mitochondrial dysfunction in acute kidney injury

Funded at Temple Univ of the Commonwealth · NIH-11085302 · Data updated 2026-11-12

This study is looking at a new way to help people with acute kidney injury by using platelets to deliver tiny energy factories called mitochondria directly to the damaged kidney cells, with the hope of preventing the injury from getting worse.

More Acute Kidney Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 4, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$311,150
NIH project number5R01DK135470-03
Project IDNIH-11085302 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are hospitalized patients who are experiencing acute kidney injury.

Less likely to help

Patients with chronic kidney disease or those who are not currently hospitalized may not benefit from this research.

What this research studies

This research investigates a novel approach to treat acute kidney injury (AKI) by using platelets to deliver mitochondria directly to damaged kidney cells. The principal investigator, with expertise in platelet structure, collaborates with specialists in kidney disease and mitochondrial function to explore this innovative therapy. The goal is to halt the progression of AKI to more severe conditions like end-stage renal disease, which currently has no effective pharmacological treatments. By focusing on the cellular mechanisms involved in kidney injury, this research aims to provide a new therapeutic strategy for affected patients.

Why it matters

Potential benefit: If successful, this research could significantly improve kidney function recovery and reduce the risk of progression to chronic kidney disease in patients with acute kidney injury.

How similar studies have gone: While the approach of using mitochondria transplantation is innovative, similar strategies in other contexts have shown promise, suggesting potential for success in this area as well.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Bouchareb, Rihab — Temple Univ of the Commonwealth
  • Study coordinator: Bouchareb, Rihab

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.